RI Related News

비회원이 작성한 글입니다!

글작성시 입력했던 비밀번호를 입력해주세요.

List Next Prev
게시글 내용
NRC issues operating license application review schedule for SHINE

SHINE Medical Technologies LLC announced today that the U.S. Nuclear Regulatory Commission (NRC) expects to make a final determination regarding the issuance of an operating license to SHINE by October 2021. SHINE’s application for a license to operate the medical isotope production facility that it is building in Janesville, Wis., was accepted and docketed by the NRC last October.


The review schedule established by the NRC for our application reflects the quality of our submission, our effective engagement with NRC staff, and the diligence and hard work of the entire SHINE team,” said Greg Piefer, chief executive officer of SHINE. The review schedule also reflects a very well on prepared and engaged NRC staff. SHINE will continue to work with the NRC to advance the review of SHINE’s operating license application.”


To watch the webinar please visit:


Source: Tech Council News